Loading clinical trials...
Loading clinical trials...
Head and Intraocular Trauma Tool (HITT) for the Identification of Mild Traumatic Brain Injury
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.
Age
13 - 45 years
Sex
ALL
Healthy Volunteers
No
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Start Date
August 1, 2021
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
July 28, 2025
200
ESTIMATED participants
Head and Intraocular Trauma Tool
DEVICE
SCAT-5
DIAGNOSTIC_TEST
Lead Sponsor
Rebiscan, Inc.
Collaborators
NCT04331392
NCT05117619
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04794894